secwatch / observer
8-K filed April 14, 2023, 7:59 PM ET ticker STRO CIK 0001382101
leadership confidence high sentiment neutral materiality 0.15

Sutro Biopharma director Shalini Sharp resigns; Heidi Hunter named Audit Committee Chair

SUTRO BIOPHARMA, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Shalini Sharp

Class III Director and Chair of the Audit Committee
STRO · SUTRO BIOPHARMA, INC.
Effective
2023-04-10
Filed
April 14, 2023, 7:59 PM ET
On April 10, 2023, Shalini Sharp notified the Board of Directors (the “Board”) of Sutro Biopharma, Inc. (the “Company”) of her resignation as a Class III director and as the Chair of the Audit Committee of the Board (the “Audit Committee”), effective immediately (the “Resignation”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shalini Sharp resigned as Class III Director and Chair of the Audit Committee at SUTRO BIOPHARMA, INC..

Action
resigned
Role
Class III Director and Chair of the Audit Committee
Exact text from the filing
On April 10, 2023, Shalini Sharp notified the Board of Directors (the “Board”) of Sutro Biopharma, Inc. (the “Company”) of her resignation as a Class III director and as the Chair of the Audit Committee of the Board (the “Audit Committee”), effective immediately (the “Resignation”).
View on SEC.gov

SUTRO BIOPHARMA, INC. filing history →

Source: SEC EDGAR
accession 0000950170-23-012879
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.